256 related articles for article (PubMed ID: 23363816)
1. SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells.
Leibowitz MS; Srivastava RM; Andrade Filho PA; Egloff AM; Wang L; Seethala RR; Ferrone S; Ferris RL
Clin Cancer Res; 2013 Feb; 19(4):798-808. PubMed ID: 23363816
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes.
Leibowitz MS; Andrade Filho PA; Ferrone S; Ferris RL
Cancer Immunol Immunother; 2011 Apr; 60(4):525-35. PubMed ID: 21207025
[TBL] [Abstract][Full Text] [Related]
3. STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients.
Srivastava RM; Trivedi S; Concha-Benavente F; Hyun-Bae J; Wang L; Seethala RR; Branstetter BF; Ferrone S; Ferris RL
Cancer Immunol Res; 2015 Aug; 3(8):936-45. PubMed ID: 25972070
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of IFN-gamma-induced STAT1 tyrosine phosphorylation by human CMV is mediated by SHP2.
Baron M; Davignon JL
J Immunol; 2008 Oct; 181(8):5530-6. PubMed ID: 18832710
[TBL] [Abstract][Full Text] [Related]
5. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
[TBL] [Abstract][Full Text] [Related]
6. Role of antigen-processing machinery in the in vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL.
López-Albaitero A; Nayak JV; Ogino T; Machandia A; Gooding W; DeLeo AB; Ferrone S; Ferris RL
J Immunol; 2006 Mar; 176(6):3402-9. PubMed ID: 16517708
[TBL] [Abstract][Full Text] [Related]
7. Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53.
Kinney BLC; Gunti S; Kansal V; Parrish CJ; Saba NF; Teng Y; Henry MK; Su FY; Kwong GA; Schmitt NC
Cancer Immunol Immunother; 2024 Jan; 73(1):10. PubMed ID: 38231444
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase SHP2 promotes invadopodia formation through suppression of Rho signaling.
Tsai WC; Chen CL; Chen HC
Oncotarget; 2015 Sep; 6(27):23845-56. PubMed ID: 26204488
[TBL] [Abstract][Full Text] [Related]
9. T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice.
Liu W; Guo W; Shen L; Chen Z; Luo Q; Luo X; Feng G; Shu Y; Gu Y; Xu Q; Sun Y
Oncotarget; 2017 Jan; 8(5):7586-7597. PubMed ID: 27935860
[TBL] [Abstract][Full Text] [Related]
10. Association of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines.
Respa A; Bukur J; Ferrone S; Pawelec G; Zhao Y; Wang E; Marincola FM; Seliger B
Clin Cancer Res; 2011 May; 17(9):2668-78. PubMed ID: 21248298
[TBL] [Abstract][Full Text] [Related]
11. Autophagy facilitates IFN-gamma-induced Jak2-STAT1 activation and cellular inflammation.
Chang YP; Tsai CC; Huang WC; Wang CY; Chen CL; Lin YS; Kai JI; Hsieh CY; Cheng YL; Choi PC; Chen SH; Chang SP; Liu HS; Lin CF
J Biol Chem; 2010 Sep; 285(37):28715-22. PubMed ID: 20592027
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori infection activates Src homology-2 domain-containing phosphatase 2 to suppress IFN-γ signaling.
Wang YC; Chen CL; Sheu BS; Yang YJ; Tseng PC; Hsieh CY; Lin CF
J Immunol; 2014 Oct; 193(8):4149-58. PubMed ID: 25225672
[TBL] [Abstract][Full Text] [Related]
13. Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance.
Ferris RL; Hunt JL; Ferrone S
Immunol Res; 2005; 33(2):113-33. PubMed ID: 16234579
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens.
Morandi F; Raffaghello L; Bianchi G; Meloni F; Salis A; Millo E; Ferrone S; Barnaba V; Pistoia V
Stem Cells; 2008 May; 26(5):1275-87. PubMed ID: 18292209
[TBL] [Abstract][Full Text] [Related]
15. Regulation of SHP2 by PTEN/AKT/GSK-3β signaling facilitates IFN-γ resistance in hyperproliferating gastric cancer.
Tseng PC; Huang WC; Chen CL; Sheu BS; Shan YS; Tsai CC; Wang CY; Chen SO; Hsieh CY; Lin CF
Immunobiology; 2012 Sep; 217(9):926-34. PubMed ID: 22325465
[TBL] [Abstract][Full Text] [Related]
16. IFN-γ upregulates survivin and Ifi202 expression to induce survival and proliferation of tumor-specific T cells.
Zimmerman M; Yang D; Hu X; Liu F; Singh N; Browning D; Ganapathy V; Chandler P; Choubey D; Abrams SI; Liu K
PLoS One; 2010 Nov; 5(11):e14076. PubMed ID: 21124930
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA FAM239A promotes tumor cell proliferation and migration by regulating tyrosine phosphatase Src homology 2 domain-containing phosphatase 2 in head and neck squamous cell carcinoma.
Li Y; Guo Y; Liu Z; Mou Y; Fang H; Yang Y; Zhao X; Zhang H; Song X
Arch Oral Biol; 2023 Mar; 147():105615. PubMed ID: 36630765
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal regulation of TLR2-mediated IFN-β production by SHP2 and Gsk3β.
Park JH; Ko R; Lee SY
Sci Rep; 2017 Jul; 7(1):6807. PubMed ID: 28754897
[TBL] [Abstract][Full Text] [Related]
20. HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancers.
Pai SI; Jack Lee J; Carey TE; Westra WH; Ferrone S; Moore C; Mosunjac MB; Shin DM; Ferris RL;
Oral Oncol; 2018 Feb; 77():92-97. PubMed ID: 29362132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
